Biblio

Export 157 results:
[ Author(Desc)] Title Type Year
Filters: First Letter Of Last Name is H  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
H
M. Hashimoto, Yamazaki, A., Ohno, A., Kimura, T., Winblad, B., and Tjernberg, L. O., “A Fragment of S38AA is a Novel Plasma Biomarker of Alzheimer's Disease.”, J Alzheimers Dis, vol. 71, no. 4, pp. 1163-1174, 2019.
Y. Hatada, Hashimoto, M., Shiraishi, S., Ishikawa, T., Fukuhara, R., Yuki, S., Tanaka, H., Miyagawa, Y., Kitajima, M., Uetani, H., Tsunoda, N., Koyama, A., and Ikeda, M., “Cerebral Microbleeds Are Associated with Cerebral Hypoperfusion in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 71, no. 1, pp. 273-280, 2019.
A. Hatami, Monjazeb, S., and Glabe, C., “The Anti-Amyloid-β Monoclonal Antibody 4G8 Recognizes a Generic Sequence-Independent Epitope Associated with α-Synuclein and Islet Amyloid Polypeptide Amyloid Fibrils.”, J Alzheimers Dis, vol. 50, no. 2, pp. 517-25, 2016.
S. Hatashita and Wakebe, D., “Amyloid-β Deposition and Long-Term Progression in Mild Cognitive Impairment due to Alzheimer's Disease Defined with Amyloid PET Imaging.”, J Alzheimers Dis, vol. 57, no. 3, pp. 765-773, 2017.
Y. Hattori, Maki, T., Saito, S., Yamamoto, Y., Nagatsuka, K., and Ihara, M., “Influence of Low-Dose Aspirin on Cerebral Amyloid Angiopathy in Mice.”, J Alzheimers Dis, vol. 52, no. 3, pp. 1037-45, 2016.
G. Hautecloque-Raysz, Sellal, F., Bousiges, O., Phillipi, N., Blanc, F., and Cretin, B., “Epileptic Prodromal Alzheimer's Disease Treated with Antiseizure Medications: Medium-Term Outcome of Seizures and Cognition.”, J Alzheimers Dis, vol. 94, no. 3, pp. 1057-1074, 2023.
K. M. Hawkins and Sergio, L. E., “Adults at Increased Alzheimer's Disease Risk Display Cognitive-Motor Integration Impairment Associated with Changes in Resting-State Functional Connectivity: A Preliminary Study.”, J Alzheimers Dis, vol. 53, no. 3, pp. 1161-72, 2016.
J. Haworth, Phillips, M., Newson, M., Rogers, P. J., Torrens-Burton, A., and Tales, A., “Measuring Information Processing Speed in Mild Cognitive Impairment: Clinical Versus Research Dichotomy.”, J Alzheimers Dis, vol. 51, no. 1, pp. 263-75, 2016.
K. Hayashi, Gonzales, T. K., Kapoor, A., Ziegler, T. E., Meethal, S. Vadakkadat, and Atwood, C. S., “Development of Classification Models for the Prediction of Alzheimer's Disease Utilizing Circulating Sex Hormone Ratios.”, J Alzheimers Dis, vol. 76, no. 3, pp. 1029-1046, 2020.
C. C. Hays, Zlatar, Z. Z., Meloy, M. J., Osuna, J., Liu, T. T., Galasko, D. R., and Wierenga, C. E., “Anterior Cingulate Structure and Perfusion Is Associated with Cerebrospinal Fluid Tau Among Cognitively Normal Older Adult APOEɛ4 Carriers.”, J Alzheimers Dis, vol. 73, no. 1, pp. 87-101, 2020.
J. - T. He, Zhao, X., Xu, L., and Mao, C. - Y., “Vascular Risk Factors and Alzheimer's Disease: Blood-Brain Barrier Disruption, Metabolic Syndromes, and Molecular Links.”, J Alzheimers Dis, vol. 73, no. 1, pp. 39-58, 2020.
X. - Y. He, Dobkin, C., W Brown, T., and Yang, S. - Y., “3-Hydroxyacyl-CoA and Alcohol Dehydrogenase Activities of Mitochondrial Type 10 17β-Hydroxysteroid Dehydrogenase in Neurodegeneration Study.”, J Alzheimers Dis, vol. 88, no. 4, pp. 1487-1497, 2022.
G. He, Luo, W., Li, P., Remmers, C., Netzer, W. J., Hendrick, J., Bettayeb, K., Flajolet, M., Gorelick, F., Wennogle, L. P., and Greengard, P., “Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease.”, Nature, vol. 467, no. 7311, pp. 95-8, 2010.
X. - Y. He, Isaacs, C., and Yang, S. - Y., “Roles of Mitochondrial 17β-Hydroxysteroid Dehydrogenase Type 10 in Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 2, pp. 665-673, 2018.
F. He, Luo, H., Yin, L., Roosaar, A., Axéll, T., Zhao, H., and Ye, W., “Poor Oral Health as a Risk Factor for Dementia in a Swedish Population: A Cohort Study with 40 Years of Follow-Up.”, J Alzheimers Dis, vol. 92, no. 1, pp. 171-181, 2023.
D. Head, Bugg, J. M., Goate, A. M., Fagan, A. M., Mintun, M. A., Benzinger, T., Holtzman, D. M., and Morris, J. C., “Exercise Engagement as a Moderator of the Effects of APOE Genotype on Amyloid Deposition.”, Arch Neurol, vol. 69, no. 5, pp. 636-43, 2012.
E. Healy, “Impact of the MIND Diet on Cognition in Individuals with Dementia.”, J Alzheimers Dis, vol. 96, no. 3, pp. 967-977, 2023.
M. Heath, Shellington, E., Titheridge, S., Gill, D. P., and Petrella, R. J., “A 24-Week Multi-Modality Exercise Program Improves Executive Control in Older Adults with a Self-Reported Cognitive Complaint: Evidence from the Antisaccade Task.”, J Alzheimers Dis, vol. 56, no. 1, pp. 167-183, 2017.
M. Heath, Weiler, J., Gregory, M. A., Gill, D. P., and Petrella, R. J., “A Six-Month Cognitive-Motor and Aerobic Exercise Program Improves Executive Function in Persons with an Objective Cognitive Impairment: A Pilot Investigation Using the Antisaccade Task.”, J Alzheimers Dis, vol. 54, no. 3, pp. 923-931, 2016.
D. M. Hedderich, Spiro, J. E., Goldhardt, O., Kaesmacher, J., Wiestler, B., Yakushev, I., Zimmer, C., Boeckh-Behrens, T., and Grimmer, T., “Increasing Diagnostic Accuracy of Mild Cognitive Impairment due to Alzheimer's Disease by User-Independent, Web-Based Whole-Brain Volumetry.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1459-1467, 2018.
M. Heffernan, Mather, K. A., Xu, J., Assareh, A. A., Kochan, N. A., Reppermund, S., Draper, B., Trollor, J. N., Sachdev, P., and Brodaty, H., “Alcohol Consumption and Incident Dementia: Evidence from the Sydney Memory and Ageing Study.”, J Alzheimers Dis, vol. 52, no. 2, pp. 529-38, 2016.
M. Heffernan, Andrews, G., Singh, M. A. Fiataron, Valenzuela, M., Anstey, K. J., Maeder, A. J., McNeil, J., Jorm, L., Lautenschlager, N. T., Sachdev, P. S., Ginige, J. A., Hobbs, M. J., Boulamatsis, C., Chau, T., Cobiac, L., Cox, K. L., Daniel, K., Flood, V. M., Guerrero, Y., Gunn, J., Jain, N., Kochan, N. A., Lampit, A., Mavros, Y., Meiklejohn, J., Noble, Y., O'Leary, F., Radd-Vagenas, S., Walton, C. C., and Brodaty, H., “Maintain Your Brain: Protocol of a 3-Year Randomized Controlled Trial of a Personalized Multi-Modal Digital Health Intervention to Prevent Cognitive Decline Among Community Dwelling 55 to 77 Year Olds.”, J Alzheimers Dis, vol. 70, no. s1, pp. S221-S237, 2019.
J. Heinrich, Vidal, J. - S., Simon, A., Rigaud, A. - S., Hanon, O., Epelbaum, J., Viollet, C., and Duron, E., “Relationships Between Lower Olfaction and Brain White Matter Lesions in Elderly Subjects with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1133-1141, 2018.
A. Heller, Coffman, S. S., and Jarvis, K., “Potentially Pathogenic Calcium Oxalate Dihydrate and Titanium Dioxide Crystals in the Alzheimer's Disease Entorhinal Cortex.”, J Alzheimers Dis, vol. 77, no. 2, pp. 547-550, 2020.
S. Hendriks, Peetoom, K., Tange, H., van Bokhoven, M. A., van der Flier, W. M., Bakker, C., Papma, J. M., Koopmans, R., Verhey, F., Köhler, S., and de Vugt, M., “Pre-Diagnostic Symptoms of Young-Onset Dementia in the General Practice up to Five Years Before Diagnosis.”, J Alzheimers Dis, vol. 88, no. 1, pp. 229-239, 2022.

Pages